15.437 articles found

Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Sudo A, Honzawa S, Nonaka I, Goto YI.

J Hum Genet · 2004-01-17

DOI: 10.1007/s10038-003-0116-1PMID: 14730434

What is the relationship between clinical phenotype and the development of dementia in idiopathic Parkinson's disease?

Dunn EM.

· 2004-01-01

Review of NMDA antagonist-induced neurotoxicity and implications for clinical development.

Low SJ, Roland CL.

Int J Clin Pharmacol Ther · 2004-01-01

DOI: 10.5414/cpp42001PMID: 14756381

Implantation of Spheramine in advanced Parkinson's disease (PD).

Bakay RA, Raiser CD, Stover NP, Subramanian T, Cornfeldt ML, Schweikert AW, Allen RC, Watts R.

Front Biosci · 2004-01-01

DOI: 10.2741/1217PMID: 14766394

[Clinical features of an early stage of Parkinson's disease].

Selikhova MV, Piatnitskiĭ AN, Aristova RA, Serkin GV, Gusev EI.

Zh Nevrol Psikhiatr Im S S Korsakova · 2004-01-01

PMID: 14870687

[A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease].

Krivonos OV, Fedorova NV, Chigir' IP.

Zh Nevrol Psikhiatr Im S S Korsakova · 2004-01-01

PMID: 14870689

[Clinical and stabilometric analysis of postural instability in Parkinson's disease].

Karpova EA, Ivanova-Smolenskaia IA, Chernikova LA, Markova ED, Illarioshkin SN.

Zh Nevrol Psikhiatr Im S S Korsakova · 2004-01-01

PMID: 14870691

[Stem cells: general characteristics and perspectives of their clinical use].

Vermel' AE.

Klin Med (Mosk) · 2004-01-01

PMID: 15022588

[Biochemical and immunological induces of the blood in Parkinson's disease and their correction with the help of laser therapy].

Komel'kova LV, Vitreshchak TV, Zhirnova IG, Poleshchuk VV, Stvolinskiĭ SL, Mikhaĭlov VV, Gannushkina IV, Piradov MA.

Patol Fiziol Eksp Ter · 2004-01-01

PMID: 15052871

Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience.

Fernandez HH, Trieschmann ME, Friedman JH.

Clin Neuropharmacol · 2004-01-01

DOI: 10.1097/00002826-200401000-00003PMID: 15090928

Effect of riluzole on dyskinesia and duration of the on state in Parkinson disease patients: a double-blind, placebo-controlled pilot study.

Braz CA, Borges V, Ferraz HB.

Clin Neuropharmacol · 2004-01-01

DOI: 10.1097/00002826-200401000-00008PMID: 15090933

Dopaminergic hypersensitivity in patients with Parkinson disease and migraine.

Cubo E, Kompoliti K, Leurgans SE, Raman R.

Clin Neuropharmacol · 2004-01-01

DOI: 10.1097/00002826-200401000-00009PMID: 15090934